Results 241 to 250 of about 3,347,409 (388)
Considerations for drug trials in hypertrophic cardiomyopathy
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant+17 more
wiley +1 more source
A Case Report: Post-Mortem Pathological Observations of a Fresh Dairy Cow with Type 3 Abomasal Ulcer After Sudden Death. [PDF]
Šertvytytė G+9 more
europepmc +1 more source
Risk Factors of Sudden Death From Subarachnoid Hemorrhage
Joni V. Lindbohm+4 more
semanticscholar +1 more source
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh+18 more
wiley +1 more source
Case Report: Sudden death caused by methylene chloride poisoning. [PDF]
Shang R+7 more
europepmc +1 more source
Ventricular arrhythmias and sudden death in patients taking ibrutinib.
B. Lampson+11 more
semanticscholar +1 more source